These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 29354263)

  • 1. Impact of structurally modifying hyaluronic acid on CD44 interaction.
    Bhattacharya D; Svechkarev D; Souchek JJ; Hill TK; Taylor MA; Natarajan A; Mohs AM
    J Mater Chem B; 2017; 5(41):8183-8192. PubMed ID: 29354263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronic acid/polyethylene glycol nanoparticles for controlled delivery of mitoxantrone.
    Sargazi A; Kamali N; Shiri F; Heidari Majd M
    Artif Cells Nanomed Biotechnol; 2018 May; 46(3):500-509. PubMed ID: 28503952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid-nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo.
    Jian YS; Chen CW; Lin CA; Yu HP; Lin HY; Liao MY; Wu SH; Lin YF; Lai PS
    Int J Nanomedicine; 2017; 12():2315-2333. PubMed ID: 28392690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor.
    Platt VM; Szoka FC
    Mol Pharm; 2008; 5(4):474-86. PubMed ID: 18547053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells.
    Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN
    Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boronic acid-tethered amphiphilic hyaluronic acid derivative-based nanoassemblies for tumor targeting and penetration.
    Jeong JY; Hong EH; Lee SY; Lee JY; Song JH; Ko SH; Shim JS; Choe S; Kim DD; Ko HJ; Cho HJ
    Acta Biomater; 2017 Apr; 53():414-426. PubMed ID: 28216300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronan magnetic nanoparticle for mitoxantrone delivery toward CD44-positive cancer cells.
    Sargazi A; Shiri F; Keikha S; Majd MH
    Colloids Surf B Biointerfaces; 2018 Nov; 171():150-158. PubMed ID: 30025377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tunable CD44-specific cellular retargeting with hyaluronic acid nanoshells.
    Ebbesen MF; Olesen MT; Gjelstrup MC; Pakula MM; Larsen EK; Hansen IM; Hansen PL; Mollenhauer J; Malle BM; Howard KA
    Pharm Res; 2015 Apr; 32(4):1462-74. PubMed ID: 25361867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors.
    Ganesh S; Iyer AK; Morrissey DV; Amiji MM
    Biomaterials; 2013 Apr; 34(13):3489-502. PubMed ID: 23410679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-pot preparation of hyaluronic acid-coated iron oxide nanoparticles for magnetic hyperthermia therapy and targeting CD44-overexpressing cancer cells.
    Soleymani M; Velashjerdi M; Shaterabadi Z; Barati A
    Carbohydr Polym; 2020 Jun; 237():116130. PubMed ID: 32241421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular delivery and antitumor effects of a redox-responsive polymeric paclitaxel conjugate based on hyaluronic acid.
    Yin S; Huai J; Chen X; Yang Y; Zhang X; Gan Y; Wang G; Gu X; Li J
    Acta Biomater; 2015 Oct; 26():274-85. PubMed ID: 26300335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfation modulates the targeting properties of hyaluronic acid to P-selectin and CD44.
    Bhattacharya DS; Svechkarev D; Bapat A; Patil P; Hollingsworth MA; Mohs AM
    ACS Biomater Sci Eng; 2020 Jun; 6(6):3585-3598. PubMed ID: 32617404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid conjugated β-cyclodextrin-oligoethylenimine star polymer for CD44-targeted gene delivery.
    Yin H; Zhao F; Zhang D; Li J
    Int J Pharm; 2015 Apr; 483(1-2):169-79. PubMed ID: 25681725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Hyaluronic Acid-Based Nanocarrier Incorporating Doxorubicin and Cisplatin as a pH-Sensitive and CD44-Targeted Anti-Breast Cancer Drug Delivery System.
    Yu T; Li Y; Gu X; Li Q
    Front Pharmacol; 2020; 11():532457. PubMed ID: 32982750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cationic conjugated polymer/fluoresceinamine-hyaluronan complex for sensitive fluorescence detection of CD44 and tumor-targeted cell imaging.
    Huang Y; Yao X; Zhang R; Ouyang L; Jiang R; Liu X; Song C; Zhang G; Fan Q; Wang L; Huang W
    ACS Appl Mater Interfaces; 2014; 6(21):19144-53. PubMed ID: 25278260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Hyaluronic Acid Conjugates for Dual Nuclear Imaging and Therapy in CD44-Expressing Tumors in Mice
    Dubey RD; Klippstein R; Wang JT; Hodgins N; Mei KC; Sosabowski J; Hider RC; Abbate V; Gupta PN; Al-Jamal KT
    Nanotheranostics; 2017; 1(1):59-79. PubMed ID: 29071179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronan-based nanocarriers with CD44-overexpressed cancer cell targeting.
    Song S; Qi H; Xu J; Guo P; Chen F; Li F; Yang X; Sheng N; Wu Y; Pan W
    Pharm Res; 2014 Nov; 31(11):2988-3005. PubMed ID: 24842660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted intracellular protein delivery based on hyaluronic acid-green tea catechin nanogels.
    Liang K; Ng S; Lee F; Lim J; Chung JE; Lee SS; Kurisawa M
    Acta Biomater; 2016 Mar; 33():142-52. PubMed ID: 26785145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dually folate/CD44 receptor-targeted self-assembled hyaluronic acid nanoparticles for dual-drug delivery and combination cancer therapy.
    Song L; Pan Z; Zhang H; Li Y; Zhang Y; Lin J; Su G; Ye S; Xie L; Li Y; Hou Z
    J Mater Chem B; 2017 Sep; 5(33):6835-6846. PubMed ID: 32264333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF; Zhu D; Bourguignon LY
    J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.